« Previous
Next »
Seminars in Hematology
Volume 43, Issue 1
, Pages 42-52
, January 2006
The Lung as a Target Organ of Graft-Versus-Host Disease
References
- . NHLBI Workshop Summary (Idiopathic pneumonia syndrome after bone marrow transplantation) . Am Rev Respir Dis . 1993;147:1601–1606
- . Clinical course of idiopathic pneumonia after bone marrow transplantation . Am Rev Respir Dis . 1993;147:1393–1400
- Interstitial pneumonitis after bone marrow transplantation . Ann Intern Med . 1986;104:168–175
- . Acute graft versus host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia . Bone Marrow Transplant . 1993;12:225–231
- Idiopathic pneumonia syndrome (Changing spectrum of lung injury after marrow transplantation) . Transplantation . 1997;63:1079–1086
- . Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation . Bone Marrow Transplant . 2001;28:425–434
- Obstructive lung disease in children after allogeneic bone marrow transplantation . Blood . 1994;84:3212–3220
- Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality . Am J Respir Crit Care Med . 1995;152:690–695
-
Late complications of allogeneic and autologous bone marrow transplantation
.
Bone Marrow Transplant
. 1992;10:127–134
- Long term follow up of immunosuppressive treatment for obstructive airway disease after allogeneic bone marrow transplantation . Bone Marrow Transplant . 1997;20:403–408
- Pulmonary function changes 100 days and one year after bone marrow transplantation . Bone Marrow Transplant . 1993;12:457–461
- Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution . Medicine . 1988;67:175–186
- . The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients . Hum Pathol . 1995;26:668–675
- . Idiopathic pneumonia after bone marrow transplantation (Cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment) . Crit Care Med . 1999;27:1800–1806
- Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation . Biol Blood Marrow Transplant . 2002;8:395–400
- Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients . Am J Med . 1989;87:511–518
- . Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation (Cryptic etiology and uncertain therapy) . Bone Marrow Transplant . 2000;26:539–543
- Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation . Bone Marrow Transplant . 2001;27:1299–1303
- . Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer . Am J Respir Crit Care Med . 1998;157:565–573
- Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support . Am J Respir Crit Care Med . 2000;161:17–25
- . Marrow engraftment and clincial manifestations of capillary leak syndrome . Bone Marrow Transplant . 1996;18:177–184
- Risk factors for interstitial pneumonitis following bone marrow transplantation for severe aplastic anemia . Br J Haematol . 1989;71:535–543
- Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation . Int J Radiat Oncol Biol Phys . 2002;52:483–488
- Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation . Blood . 2003;102:2777–2785
- . The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation . Transplantation . 1992;54:802–808
- . Idiopathic pneumonia syndrome after bone marrow transplantation (The role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis) . Int J Exp Pathol . 2001;82:101–113
- . Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis . Nature . 1990;344:245–247
- . Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin-1. A potential role for interleukin-1 in the pathogenesis of silicosis . J Clin Invest . 1984;73:1462–1472
- . High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis . Am Rev Respir Dis . 1992;145:1016–1022
- . Temporal relationships between the major complications of bone marrow transplantation for leukemia . Bone Marrow Transplant . 1989;4:339–344
- . Lymphocytic bronchitis associated with graft versus host disease in recipients of bone marrow transplants . N Engl J Med . 1978;299:1030–1036
- Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor MRNA and chronic interstitial pneumonitis . Lab Invest . 1989;61:37–45
- . Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages . J Immunol . 1998;161:1913–1920
- An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin . Blood . 1996;88:3230–3239
- Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation . Blood . 1998;92:2571–2580
-
.
Large airway inflammation as a possible manifestation of a pulmonary graft-versus-host reaction in bone marrow allograft recipients
.
Lab Invest
. 1981;44:26A
-
.
Pulmonary pathology in bone marrow transplant recipients
.
Lab Invest
. 1982;46:3
- The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogenic recipients are due to donor T cell infusion and potentiated by cyclophoshamide . J Clin Invest . 1997;100:1015–1027
- . Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation . Bone Marrow Transplant . 1995;16:169–173
- . Risk factors for air-flow obstruction in recipients of bone marrow transplants . Ann Intern Med . 1987;107:648–656
- Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome . J Immunol . 2004;173:2050–2059
-
.
A role for Fas-Fas ligand but not perforin mediated cytolysis in the development of experimental idiopathic pneumonia syndrome
.
Blood
. 2000;96:768a
- Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation . Blood . 2004;104:586–593
- . Dendritic-cell regulation of lung immunity . Am J Respir Cell Mol Biol . 1997;17:284–286
- Regulation of rat pulmonary dendritic cell immunostimulatory activity by alveolar epithelial cell-derived granulocyte macrophage colony-stimulating factor . Am J Respir Cell Mol Biol . 1995;13:426–433
- . Distribution and immunophenotype of mononuclear and dendritic cells in the human lung . Am J Respir Cell Mol Biol . 1994;10:487–492
- . Potential role of dendritic cells in bronchiolitis obliterans in heart-lung transplantation . Ann Thorac Surg . 1990;49:424–428
- . Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways . J Immunol . 1994;153:256–261
- . Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease . J Exp Med . 1987;166:1280–1289
- Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation . Transplantation . 2000;70:272–279
- Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome (Potential role for a gut-lung axis of inflammation) . J Immunol . 2000;165:6612–6619
- Tumor necrosis factor-a production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft versus host disease . J Clin Invest . 1998;102:1882–1891
- Differential effects of anti-Fas ligand and anti-tumor necrosis factor-a antibodies on acute graft-versus-host disease pathologies . Blood . 1998;91:4051–4055
- . Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice . Transplantation . 1995;60:1371–1374
- . Neutralization of tumor necrosis factor-alpha action delays but does not prevent lung injury induced by alloreactive T helper 1 cells . Transplantation . 2000;70:39–43
- . High levels of peroxynitrite are generated in the lungs of irradiated mice given cyclophosphamide and allogeneic T cells (A potential mechanism of injury after marrow transplantation) . Am J Respir Cell Mol Biol . 1999;20:1125–1135
- . The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease (Rationale for the use of cytokine shields in allogeneic bone marrow transplantation) . Blood . 2000;95:2754–2759
- LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation . J Clin Invest . 2001;107:1581–1589
- . The gut mucosal barrier in bone marrow transplantation . Bone Marrow Transplant . 1990;5:373–377
- . The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease . J Endotoxin Res . 2002;8:441–448
- Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14 . Am J Physiol Lung Cell Mol Physiol . 2001;280:L58–L68
- . Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy . J Pediatr Hematol Oncol . 2003;25:801–805
-
Survival following etantercept therapy for the treatment of idiopathic pneumonia syndrome following allogeneic stem cell transplantation
.
Blood
. 2004;104:104a
- Lung function abnormalities after bone marrow transplantation in children (Has the trend recently changed?) . Chest . 2001;120:1900–1906
- Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation (Long-term results of a randomized trial in allogeneic marrow recipients with leukemia) . Blood . 1999;93:2196–2201
- . Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease . Am Rev Respir Dis . 1984;129:641–644
- . Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course . Ann Intern Med . 1989;111:368–376
- Chronic graft-versus-host disease and other late complications of bone marrow transplantation . Semin Hematol . 1991;28:250–259
- . Radiologic-pathologic conference of Children’s Hospital Boston (New pulmonary nodules in a child undergoing treatment for a solid malignancy) . Pediatr Radiol . 1996;26:19–21
- . Overview of bronchiolitis . Clin Chest Med . 1993;14:607–610
- . High-resolution computed tomography of bronchiolitis obliterans syndrome after bone marrow transplantation . Respiration . 1998;65:187–191
- . Bronchiolitis obliterans syndrome in heart-lung transplant recipients (Diagnosis with expiratory CT) . Radiology . 2001;218:533–539
- . Bronchiolitis obliterans in chronic graft-versus-host disease (Analysis of risk factors and treatment outcomes) . Biol Blood Marrow Transplant . 2003;9:657–666
- Late pulmonary impairment following allogeneic bone marrow transplantation . Eur J Med Res . 1996;1:343–348
- . Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-versus-host disease and low serum IgG . Blood . 1988;72:621–627
- Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients . Transplantation . 2002;73:591–599
- Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome (Proinflammatory role of bronchial epithelial cells) . Transplantation . 2000;70:362–367
- . Pulmonary fibrosis (Cytokines in the balance) . Eur Respir J . 1998;11:1218–1221
- Transfer of tumor necrosis factor-a to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-b1 and myofibroblasts . Am J Pathol . 1998;153:825–832
- Expression of a tumor necrosis factor-a transgene in murine lung causes lymphocytic and fibrosing alveolitis . J Clin Invest . 1995;96:250–259
- Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation . Chest . 1993;104:114–118
- . Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation . Transplantation . 2004;77:1465–1467
- . Maintenance azithromycin therapy for bronchiolitis obliterans syndrome (Results of a pilot study) . Am J Respir Crit Care Med . 2003;168:121–125
- Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation (A preliminary study) . Eur Respir J . 2005;25:490–493
- . Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease . Transplantation . 2002;73:665–667
-
Etanercept for sub-acute lung injury following allogeneic stem cell transplantation
.
Blood
. 2003;102:471a
K.R.C. is an Amy Strelzer-Manasevit Scholar of the National Marrow Donor Program, a Fellow of the Robert Wood Johnson Minority Faculty Development Program, a Leukemia and Lymphoma Society Scholar in Clinical Research and the recipient of a Clinical Scientist Award in Translational Research from the Burroughs Wellcome Fund.
PII: S0037-1963(05)00170-8
doi: 10.1053/j.seminhematol.2005.09.004
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Hematology
Volume 43, Issue 1
, Pages 42-52
, January 2006
